Wet AMD: Rapid Central Vision Loss, Symptoms, Diagnosis and Treatments
Wet AMD can cause fast central vision loss. Learn symptoms, diagnosis, treatments like anti-VEGF injections, and lifestyle steps to protect sight. Act fast.
Wet age-related macular degeneration, commonly called wet AMD, is an advanced eye disease that can produce sudden and severe central vision loss. The condition arises when abnormal blood vessels grow under the macula and leak fluid or blood, damaging the part of the retina needed for reading, recognizing faces, and driving. Early recognition and timely treatment are critical to preserving sight.
Wet AMD Causes Rapid Central Vision Loss
Wet AMD occurs when new, fragile blood vessels beneath the macula begin to leak, a process known as neovascularization. These vessels can cause swelling, scarring, and a rapid decline in central vision that may unfold over days or weeks. Although only a minority of people with age-related macular degeneration develop the wet form, its potential for quick progression makes it a medical priority.
Abnormal vessel growth is often triggered by cumulative damage from the more common dry form of AMD and by factors that affect retinal health. Genetic predisposition, aging retina tissues, and local inflammatory changes contribute to the environment that allows these vessels to form and leak. The result is distortion and blind spots that directly impact daily activities.
Symptoms That Signal Emergency Care
People with wet AMD typically notice changes in central vision that are distinct and alarming. Common early signs include a blurry or dark spot in the center of vision, straight lines appearing wavy, fading color perception, and difficulty seeing in dim light. These changes can affect one or both eyes and often prompt patients to seek urgent ophthalmic assessment.
Because symptoms can escalate quickly, clinicians advise anyone experiencing sudden central vision distortion or blind spots to obtain an eye examination without delay. Prompt evaluation increases the chance that effective treatments can stabilize vision and, in many cases, improve it.
How Specialists Confirm Wet AMD
Diagnosis begins with a comprehensive eye exam and a detailed symptom history, with clinicians using tools to assess both function and retinal structure. Visual acuity testing and the Amsler grid help detect central distortions, while dilation allows direct inspection of the retina. Optical coherence tomography (OCT) is the core imaging test, producing cross-sectional views that reveal fluid, hemorrhage, and retinal layer disruption.
When leakage is suspected, specialists may use fluorescein or indocyanine green angiography to map blood flow and identify leaking vessels. These targeted imaging studies guide treatment decisions by showing the location and activity of abnormal vessels, and they are often repeated during follow-up to monitor response.
Anti-VEGF Injections: The Standard of Care
Anti-VEGF medications, delivered by injection into the eye, are the first-line treatment for wet AMD and have transformed patient outcomes. These drugs block vascular endothelial growth factor (VEGF), a protein that drives new vessel growth and leakage, and regular treatment can halt progression and often restore some vision. Most patients begin with monthly injections and may transition to less frequent dosing based on disease activity and specialist assessment.
Several agents are used in clinical practice, and choice of medication, dosing interval, and long-term management are individualized. Effective anti-VEGF therapy can preserve vision in the majority of patients and lead to measurable improvement in about one-third, though strict adherence to follow-up and treatment schedules is essential.
Other Treatments and Supportive Measures
When anti-VEGF therapy is insufficient or adjunctive measures are indicated, clinicians may consider photodynamic therapy or combination approaches for selected lesion types. Photodynamic therapy uses a light-activated drug and targeted laser to close leaking vessels, and it may be paired with injections in specific cases. Rehabilitation services, low-vision aids, and counseling are important supports for patients who experience residual vision loss.
Nutritional supplements recommended for some stages of macular degeneration can slow progression and support retinal health. Supplements containing antioxidants, lutein, zeaxanthin, zinc, and copper are commonly advised for people at risk, though they do not reverse established wet AMD and should be used under medical guidance.
Reducing Risk and Protecting Vision
Some risk factors for wet AMD cannot be changed, such as age and family history, but lifestyle modifications can reduce overall risk and support eye health. Stopping smoking is among the most impactful measures, while a diet rich in leafy greens, colorful vegetables, fish high in omega-3s, and reduced processed foods supports retinal function. Managing cardiovascular risk factors, including blood pressure and obesity, also contributes to a lower likelihood of progression.
Regular, comprehensive eye examinations are essential for early detection, particularly for adults over 60 or those with a family history of macular degeneration. Timely screening allows clinicians to identify changes before significant vision loss occurs and to start treatment promptly if needed.
Early diagnosis and sustained care are the best defenses against the sudden vision decline caused by wet AMD.
